Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,290,586
+$441,639 QoQ
Shares Held
1,076
+16.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#2,899
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOWE & RUSLING INC holds $48,551,537 across 10 Drug Manufacturers - General names. LLY ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
97,901 | $24,635,807 | |
| 2 | AZN |
Astrazeneca PLC
|
42,193 | $8,000,635 | |
| 3 | JNJ |
Johnson & Johnson
|
29,374 | $7,460,114 | |
| 4 | MRK |
Merck & Co., Inc.
|
24,744 | $3,179,604 | |
| 5 | AMGN |
Amgen Inc
|
4,998 | $1,809,875 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
1,076 | $1,290,586 | |
| 7 | PFE |
Pfizer Inc
|
35,247 | $848,747 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,437 | $686,910 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,290,586 | 1,076 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $848,947 | 923 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $980,108 | 912 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $648,550 | 850 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $697,679 | 895 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $351,837 | 426 | Shares | Sole | 2025-06-17 | |
| 2024-12-31 | $286,412 | 371 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $359,691 | 406 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $638,292 | 705 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $490,892 | 631 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $367,822 | 631 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $377,065 | 702 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $327,817 | 699 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $259,625 | 756 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $325,231 | 889 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $280,667 | 868 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $210,425 | 649 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $187,285 | 654 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $177,885 | 644 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $148,796 | 644 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $149,417 | 651 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $122,180 | 654 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $118,525 | 702 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $71,789 | 485 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $91,940 | 560 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $631,037 | 4,549 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||